Company intelligence / Profile preview

Aienkang Clinical Medical Research

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Aienkang Clinical Medical Research is a China-based Contract Research Organization (CRO) that provides comprehensive clinical trial services to the pharmaceutical and biotechnology industries. The company specializes in clinical trial management, regulatory affairs, and medical writing, with a particular focus on Phase I through Phase IV clinical trials. Aienkang supports both domestic and international clients in navigating the regulatory landscape in China, ensuring compliance with National Medical Products Administration (NMPA) standards. Their service portfolio includes site selection, monitoring, data management, and statistical analysis for a variety of therapeutic areas.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Aienkang Clinical Medical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aienkang Clinical Medical Research.

Explore the full profile